Emovi 3D Knee Assessment Device Intervention for Operational Readiness

Last updated: November 8, 2024
Sponsor: Womack Army Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Emovi Knee Kinesiography

Clinical Study ID

NCT06517056
WAMC.2024.0053
  • Ages 18-50
  • All Genders

Study Summary

This is a randomized clinical trial investigating the use of the Emovi Knee Kinesiography information in the treatment of anterior knee pain in physical therapy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 18-50

  • Active Duty Service Member stationed at Fort Liberty and Schofield Barracks

  • Diagnosis of patellofemoral pain (ICD-10 codes: M25.2 (pain in unspecified knee),M25.561 (pain in right knee), and M25.562 (pain in left knee)

Exclusion

Exclusion Criteria:

  • Pregnancy

  • Known to be leaving that duty station within next 3 months

  • Concurrent lower limb injuries (examples include but are not limited to ankle sprainor HS strain)

  • Previous knee surgery

  • History of traumatic knee injury, such as a ligament tear or meniscal tear

  • Presence of rheumatoid or neurological disease

Study Design

Total Participants: 180
Treatment Group(s): 1
Primary Treatment: Emovi Knee Kinesiography
Phase:
Study Start date:
October 24, 2024
Estimated Completion Date:
October 31, 2025

Study Description

The purpose of this study is to assess the effectiveness of using a 3D medical assessment device versus usual care to help guide clinical decisions about the management of PFP. The objective is to determine if gathering objective biomechanical data from a three-dimensional (3D) motion capture device leads to more precise and optimal care, ultimately improving physical function and other outcomes compared to participants who receive routine care that is not guided by information from this device.

Participants will be recruited from primary care and physical therapy clinics at participating sites. Authorized study personnel will search electronic medical records (Genesis) to identify potential study participants diagnosed with knee pain.

After consent and enrollment, participants will complete baseline measures and then receive a Knee Kinesiography exam. The participant will be entered into the KneeKG system using a unique participant identifier. After the knee kinesiography exam with the KneeKG, participants will be randomized 1:1 into one of two different treatment arms: 1) KneeKG informed care or 2) usual care without any information from the KneeKG.

Knee mechanics during gait is assessed with a Knee Kinesiography exam. The participant will walk for 5 minutes on a commercial treadmill at their comfortable speed. Three-dimensional (3D) knee kinematics are captured on each leg using the KneeKG system (Emovi, Canada). With this validated FDA cleared medical device, there is an accurate quantification of specific knee biomechanical markers during gait in a clinical setting. There will be two 45-second trials to electronically capture the data which is immediately accessible through automatic reports. Biomechanical markers captured include but are not limited to varus/valgus alignment at stance, varus/valgus alignment at heel strike, knee flexion angle at heel strike, total knee excursion in sagittal plane, tibial rotation at heel strike and throughout gait cycle. The entire procedure will take approximately 15-20 minutes. This procedure will occur at baseline and also again at 12 weeks.

Connect with a study center

  • Tripler Army Medical Center

    Honolulu, Hawaii 96859
    United States

    Site Not Available

  • Womack Army Medical Center

    Fort Liberty, North Carolina 28310
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.